BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26989203)

  • 1. Introduction to a review series: the paradox of indolent B-cell lymphoma.
    Sehn LH
    Blood; 2016 Apr; 127(17):2045-6. PubMed ID: 26989203
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary cutaneous B-cell lymphoma: a clinically homogeneous entity?
    Pimpinelli N; Santucci M; Mori M; Vallecchi C; Giannotti B
    J Am Acad Dermatol; 1997 Dec; 37(6):1012-6. PubMed ID: 9418781
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment strategy for indolent B-cell lymphoma].
    Tobinai K
    Rinsho Ketsueki; 2001 Apr; 42(4):288-92. PubMed ID: 11400299
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of indolent cutaneous B‑cell lymphoma].
    Wobser M
    Hautarzt; 2017 Sep; 68(9):721-726. PubMed ID: 28766120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MALToma versus marginal zone lymphoma versus diffuse large B cell lymphoma.
    Ely SA
    J Gastroenterol Hepatol; 2002 Feb; 17(2):226; author reply 226-7. PubMed ID: 11966958
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary cutaneous B-cell lymphoma: subtypes, treatment and outcome of 10 cases.
    Onsun N; Su O; Kural YB; Erdemoglu Y; Buyukbabani N; Demirkesen C; Aydin Y
    Acta Derm Venereol; 2011 Jun; 91(4):476-8. PubMed ID: 21537819
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary cutaneous B-cell lymphomas - clinicopathological, prognostic and therapeutic characterisation of 54 cases according to the WHO-EORTC classification and the ISCL/EORTC TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome.
    Golling P; Cozzio A; Dummer R; French L; Kempf W
    Leuk Lymphoma; 2008 Jun; 49(6):1094-103. PubMed ID: 18569636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia.
    Quintanilla-Martinez L; Sander B; Chan JK; Xerri L; Ott G; Campo E; Swerdlow SH
    Virchows Arch; 2016 Feb; 468(2):141-57. PubMed ID: 26416032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric follicular lymphomas, marginal zone lymphomas, and marginal zone hyperplasia.
    Swerdlow SH
    Am J Clin Pathol; 2004 Dec; 122 Suppl():S98-109. PubMed ID: 15690646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biology and treatment of indolent lymphomas: follicular lymphoma and marginal zone B-cell lymphoma].
    Nishikori M
    Rinsho Ketsueki; 2009 Oct; 50(10):1332-41. PubMed ID: 19915340
    [No Abstract]   [Full Text] [Related]  

  • 11. Follicular colonization in chronic lymphocytic leukemia/small lymphocytic lymphoma (comment on "Small lymphocytic lymphoma mimicking primary cutaneous marginal zone lymphoma with colonization of germinal center follicles").
    Swerdlow SH
    J Cutan Pathol; 2021 Jan; 48(1):198-199. PubMed ID: 33410535
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoreactive B cell clones in marginal-zone B cell lymphoma (MALT lymphoma) of the stomach.
    Zucca E; Bertoni F; Roggero E; Cazzaniga G; Bosshard G; Biondi A; Cavalli F
    Leukemia; 1998 Feb; 12(2):247-9. PubMed ID: 9519790
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis C virus - associated B cell non-Hodgkin's lymphoma.
    Mihăilă RG
    World J Gastroenterol; 2016 Jul; 22(27):6214-23. PubMed ID: 27468211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cutaneous B-cell lymphoma: narrative review of the literature.
    Grandi V; Alberti Violetti S; La Selva R; Cicchelli S; Delfino C; Fava P; Fierro MT; Pileri A; Pimpinelli N; Quaglino P; Berti E
    G Ital Dermatol Venereol; 2019 Aug; 154(4):466-479. PubMed ID: 29144099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Composite Follicular Lymphoma and CD5-Positive Nodal Marginal Zone Lymphoma.
    Miyaoka M; Kikuchi T; Carreras J; Yara Kikuti Y; Omachi K; Kojima M; Ando K; Nakamura N
    J Clin Exp Hematop; 2016; 56(1):55-8. PubMed ID: 27334859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marginal zone cell lymphoma--an update on recent advances.
    Maes B; De Wolf-Peeters C
    Histopathology; 2002 Feb; 40(2):117-26. PubMed ID: 11952855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathways towards indolent B-cell lymphoma - Etiology and therapeutic strategies.
    van den Brand M; Scheijen B; Hess CJ; van Krieken JHJ; Groenen PJTA
    Blood Rev; 2017 Nov; 31(6):426-435. PubMed ID: 28802906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project.
    Nathwani BN; Anderson JR; Armitage JO; Cavalli F; Diebold J; Drachenberg MR; Harris NL; MacLennan KA; Müller-Hermelink HK; Ullrich FA; Weisenburger DD
    J Clin Oncol; 1999 Aug; 17(8):2486-92. PubMed ID: 10561313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NCCN preliminary non-Hodgkin's lymphoma practice guidelines.
    Oncology (Williston Park); 1997 Nov; 11(11A):281-46. PubMed ID: 9430195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.